1 The eect of the antiarrhythmic drug dronedarone on the Acetylcholine-activated K + current (I K(ACh) ) was investigated in single cells isolated from sinoatrial node (SAN) tissue of rabbit hearts. 2 Externally perfused dronedarone (0.001 ± 1 mM) caused a potent, voltage independent block of I K(ACh) . Fitting of the dose response curve of I K(ACh) block yielded an IC 50 value of 63 nM, a value over one order of magnitude lower than those reported for dronedarone block of other cardiac currents. 3 I K(ACh) block was not due to an inhibitory action of dronedarone on the muscarinic M2 receptor activation, since the drug was eective on I K(ACh) constitutively activated by intracellular perfusion with GTP-gS. 4 External cell perfusion with dronedarone inhibited the activity of I K(ACh) channels recorded from cell-attached patches by reducing the channel open probability (from 0.56 to 0.11) without modi®cation of the single-channel conductance. 5 These data suggest that dronedarone blocks I K(ACh) channels either by disrupting the G-proteinmediated activation or by a direct inhibitory interaction with the channel protein.
Introduction
The rate of cardiac contraction is determined by the spontaneous activity of the sinoatrial node (SAN) which re¯ects the combined electrical contribution of several ionic conductances. Sympathetic and parasympathetic stimulation aect the electrical activity of the heart by modifying some of these currents in the SAN as well as in atrial and ventricular tissue. Tonic release of ACh by the cardiac branch of the vagal system for example exerts its bradycardic action by reducing both the pacemaker (I f ) and the L-type calcium (I Ca,L ) currents (Zaza et al., 1996) and by activating, via direct G-protein coupling, a K + conductance (I K(ACh) ) (Breitwieser & Szabo, 1985; Renaudon et al., 1997) .
Pathological alterations of the physiological cardiac rhythm are generated by a variety of mechanisms and represent an area of intense investigation since they aect a substantial segment of the adult population. Amiodarone is one of the most frequently employed drugs in the therapeutic treatment of cardiac arrhythmias and is known for both its antiadrenergic properties and its direct depressant eect on many cardiac ionic conductances; unfortunately, amiodarone also determines hypothyroidism-like eects. Dronedarone (Sano®-Synthelabo) is a benzofuran derivative related to amiodarone; previous studies on several ionic currents involved in cardiac activity (I f , I K , I Na , I Ca,L , I Ca,T ) suggested that dronedarone, like amiodarone, possesses the properties of an unspeci®c ion channel blocker (Rocchetti et al., 1998) . The lack of adverse side eects in animals treated with dronedarone makes this drug potentially important for clinical use. Here we show that dronedarone is a potent inhibitor of the ACh-activated K + current (I K(ACh) ) since it blocks this current at doses over one order of magnitude smaller than those reported for other currents (Rocchetti et al., 1998) , and the high sensitivity of the block suggests that this drug is a potentially useful pharmacological tool to dissect the eect of I K(ACh) from other cardiac currents.
Methods
Protocols employed in our experiments conformed to the guidelines of the care and use of laboratory animals established by State (DL. 116/1992) and European directives (86/609/ CEE).
Cell isolation
Spontaneously active`pacemaker' myocytes were isolated from the SAN region of rabbit hearts according to the methods previously reported (DiFrancesco et al., 1986) . Brie¯y, New Zealand rabbits (0.8 ± 1.0 kg) were anaesthetized by i.m. injection of a mixture of Xilazine (4.6 mg kg 71 ; Sigma) and Ketamine (60 mg kg 71 ; Sigma). Animals were then sacri®ced by cervical dislocation and hearts quickly removed and placed in a prewarmed (378C) normal Tyrode solution (mM): NaCl 140, KCl 5.4, CaCl 2 1.8, MgCl 2 1, HEPES-NaOH 5, Glucose 5.5, pH 7.4) containing 0.1 ml heparin (5000 U ml 71 ). Anatomical isolation of the SAN was performed under a binocular microscope; the atria were separated from the ventricles and the internal wall of the right atrium was cut open to expose the SAN. Reference points for the determination of the nodal tissue were the superior and inferior venae cavae, the crista terminalis and the interatrial septum. Small strips of central nodal tissue were cut perpendicularly to the crista terminalis and initially treated in an enzyme-containing solution (mM): NaCl 140, KCl 5.4, MgCl 2 0.5, CaCl 2 0.2, KH 2 PO 4 1.2, taurine 50, glucose 5.5, HEPES-NaOH 5, albumine (BSA) 5 mg, collagenase 1120 U (Worthington), elastase 9.5 U (Sigma), protease 3 U; (Sigma) to loosen intracellular connections; this procedure was followed by a mechanical trituration in a Ca 2+ -free solution (mM): KCl 20, glutamic ac. 70, b-hydroxybutirric ac. 10, KH 2 PO 4 10, taurine 10, HEPES-KOH 80, pH 7.4. Single cells obtained after this treatment were then slowly readapted to physiological Ca 2+ concentration and stored at 48C until ready for the experiment.
Experimental methods and solutions
The whole-cell con®guration of the patch-clamp technique was used to study the eect of the benzofuran derivative N,Ndibutyl-3-[4-((2-butyl-5-methylsulphonamido) benzofuran-3-yl-carbonyl)phenoxy] propylamine, hydrochloride: (Dronedarone by Sano® Synthelabo) on the I K(ACh) current. Petri dishes containing isolated cells were placed on the stage of an inverted microscope and superfused with the control solution. In order to increase the size of the K + current investigation the external control solution was a high K + Tyrode containing (mM): NaCl 140, KCl 25, MgCl 2 1, CaCl 2 1.8, HEPES NaOH 5, Glucose 5.5, CsCl 5 and MnCl 2 2 were added to block the pacemaker (I f ) and Ca L-type currents. I K(ACh) was elicited by adding ACh (10 mM) to the control solution. Dierent concentrations of dronedarone were prepared by diluting a 5 mM stock solution (3 mg ml 71 ethanol). Ethanol was also added to the control and ACh-containing solutions; in pilot experiments we veri®ed that addition of ethanol had no eects on the size and time course of the current elicited by ACh (not shown). Whole-cell patch pipettes were ®lled with an intracellular-like solution (mM): K-Aspartate 130, NaCl 10, EGTA KOH 5, HEPES-KOH 10, CaCl 2 2, MgCl 2 2, ATP(Na 2 ) 2, creatine phosphate 5, GTP 0.1, pH 7.2), and had a resistance of 2 ± 4 MO. In some whole-cell experiments guanosine 5'-O-(3-thiotriphosphate) (GTP-gS, 100 mM), a non-hydrolizable analogue of GTP, was added to the pipette solution to induce irreversible activation of I K(ACh) channels.
Single-channel data were recorded in the cell-attached con®guration; the extracellular solution in the recording pipettes was (mM): KCl 150, CaCl 2 1.8, HEPES 5, pH 7.4, ACh (0.1 mM) was added to the pipette solution to activate the muscarinic receptor. Sylgard coating (Levis & Rae, 1993) was employed to reduce pipette capacitance and improve the signal-to-noise ratio. A high K + bath solution (mM): KCl 130, NaCl 10, HEPES-KOH 5, MgCl 2 2, glucose 10, MnCl 2 2, pH 7.4 was used to zero the cell resting potential and to allow for a precise control of membrane potential during the experiment.
Control and test solutions were delivered to the cell under investigation through a fast-perfusion device; all experiments were carried out at room temperature (20 ± 248C). Electrophysiological measurements were performed with pClamp 7.0 software and an Axopatch 200B ampli®er (Axon Instruments, Inc., Foster City, CA, U.S.A.). Software developed in our laboratory was also utilized.
Results
To activate the ACh-dependent K + current, cells were held at dierent holding potentials and superfused with ACh (10 mM) for 10 s. The current elicited by ACh had a rapid onset followed by a slowly developing decay, reversed at voltages near the predicted E K and disappeared upon wash o of ACh; these properties con®rmed that the current under investigation was the ACh-activated K + current (Carmeliet & Mubagwa, 1986) . Figure 1 illustrates a typical experiment where the action of dronedarone on I K(ACh) was tested. After the wholecell con®guration was established and a stable holding current recorded in control conditions, we tested for the presence of I K(ACh) by 10 s perfusion with ACh (10 mM). The cell was then exposed for at least 3 min (to allow full development of its action) to dronedarone (300 nM) and ACh was again perfused in the presence of the drug. This protocol was repeated at dierent voltages and sample traces recorded at 0, 730 and 760 mV are superimposed in Figure 1a . In all cases dronedarone (300 nM, traces labelled by asterisks) caused a marked block of I K(ACh) , which did not appear to be dependent upon current direction.
The same protocol was repeated using dierent holding potentials and dronedarone concentrations in a total of 27 cell, and mean current-voltage (I-V) relations for I K(ACh) and dronedarone-sensitive currents normalized to cell capacity are shown in Figure 1b . Control and drug-sensitive current amplitudes, measured as the dierence between peak and baseline current levels, were plotted against holding potentials.
Figure 1 Eect of dronedarone on I K(ACh) elicited by ACh (10 mM). (a) ACh-induced current recorded in three cells before and after 3 min exposure to dronedarone (300 nM, asterisks) at holding potentials of 0, 730 and 760 mV (left to right). (b) Mean current-voltage (I-V) relations for I K(ACh) (n=7) and dronedaronesensitive current (n=7). Current amplitudes were measured as the dierence between the peak and the baseline and normalized to cell capacity. Linear regression in the range 760 to 0 mV yielded slope conductances of 0.41 and 0.34 pS pF 71 , and reversal potentials of 728.9 and 728.1 mV for the ACh-activated and dronedaroneblocked components, respectively.
Reversal potentials for I K(ACh) and dronedarone-sensitive currents, calculated by ®tting the linear part of the curves, were 728.7+1.1 (n=7) and 729.3+0.9 (n=7), respectively; these values are not signi®cantly dierent (P50.05). A comparison between the two I-V curves shows a similar voltage dependence, suggesting lack of voltage dependence of channel blockade. It also appears that both I-V relations display a reduction of conductance at voltages negative to 760 mV. A conductance decrease may result from a voltagedependent channel blocking action of external Cs + ions, which becomes evident at the most negative potentials investigated (Carmeliet & Mubagwa, 1986) . The inward rectifying nature of the ACh-induced K + current was con®rmed by extending the analysis of the I-V relation to positive voltages (n=6, data not shown).
The lack of voltage dependence of dronedarone-induced I K(ACh) block was con®rmed by the analysis shown in Figure 2 .
Fractional current inhibition was calculated from data as those in Figure 1a as the ratio between dierence current amplitude in the presence and absence of the drug and control current amplitude. Data points represent mean+s.e.mean values obtained at dierent potentials in n=6 ± 9 cells. A correlation index of 0.014 obtained by regression analysis con®rmed that dronedarone block of the I K(ACh) channel is independent from membrane voltage.
To investigate the concentration-dependence of the block, we measured I K(ACh) at a ®xed voltage (0 mV) before and during drug exposure. In Figure 3a the results from three representative cells are plotted. Since drug-induced block of I K(ACh) was not fully reversible we used a single drug concentration for each cell to avoid cumulative eects.
To avoid desensitization of the current response to muscarinic receptor activation during prolonged exposures (Boyett & Roberts, 1987) , we measured the dronedaroneinduced current block by comparing peak currents obtained upon short (10 s) ACh exposures before and after 3 min perfusion with dronedarone. In pilot experiments we veri®ed that there was no signi®cant I K(ACh) current change within this time (average change after 3 min from ®rst ACh application in three control cells was 75.07+5.21%, not signi®cantly dierent from zero, P40.1).
From the sample data shown in Figure 3 , it appears that even concentrations as low as 1 nM induced a measurable reduction of the peak ACh-activated K + current. A doseresponse curve of I K(ACh) block is shown in Figure 3b where mean+s.e.mean fractional block values, as measured on the peak current, are plotted for concentrations of dronedarone in the range 1 ± 1000 nM. Fitting of the dose-response data with the Hill equation yielded a half-block value (IC 50 ) of 63.4 nM and a Hill coecient of 0.61.
Since the activation of I K(ACh) depends on a G-proteinmediated interaction between muscarinic receptors and Figure 2 Lack of voltage-dependence of dronedarone-induced block on I K(ACh) . Data points were calculated as the ratio between the dierence of peak currents in control and after addition of the drug (300 nM), and control peak amplitude, and represent the mean fractional inhibition obtained at dierent potentials (n=6 ± 9) for each potential. channel proteins, dronedarone could act by uncoupling this cascade of events at dierent levels. In order to dissect possible eects of dronedarone on the receptor-G-protein interaction from downstream events, we tested the action of the drug after constitutively activating the G-proteins by intracellular perfusion with GTP-g-S. Immediately after establishing the whole-cell con®guration, I K(ACh) was activated at 0 mV by a 10 s perfusion with ACh (10 mM, Figure 4 ). Under these conditions, I K(ACh) activation was nearly fully reversible upon ACh wash out. Following return of the current towards the baseline, a slow upward current de¯ection started to develop. To verify if this behaviour re¯ected activation of I K(ACh) by GTP-gS-induced G-protein activation following cell dialysis, we applied ACh at dierent times during development of the outward current. In accordance with this hypothesis, the current stimulated by ACh progressively decreased with time until it was fully abolished after about 400 s after establishment of whole-cell conditions. Lack of response to ACh and the attainment of a stable level of outward current developed during whole-cell recording were taken as indication that the ACh-activated K + current was fully activated. Perfusion of dronedarone at this point produced a slow decrease of the current to a level similar to the one at the beginning of the experiment. The decay could be ®tted by a single exponential time course with a time constant of 29.9 s.
Further perfusion of ACh did not elicit any current responses. We obtained similar results in a total of seven cells at two dierent voltages (0 mV, n=5; 780 mV, n=2). These data rule in favour of the hypothesis that dronedarone acts either by functionally uncoupling the G-protein channel interaction or by directly binding to the channel.
Channel blockers can act by reducing the single channel conductance and/or by modifying the probability of channel openings (Hille, 1992) . We performed single-channel experiments in the cell-attached con®guration in order to test whether bath perfusion with dronedarone could induce the block of channels present in the recording pipette. Patch pipettes containing ACh (0.1 mM) were sealed onto the cell membrane and channel activity was recorded in control conditions and during perfusion with dronedarone (300 nM). In Figure 5 , sample traces and all-points distributions obtained from a typical experiment are shown.
Single channel events measured at 780 mV (20 s 
Discussion and conclusions
Acetylcholine is a neurotransmitter playing a key role in the modulation of many heart functions (Wickman et al., 1998) . Drugs that mimic or antagonize the eect of ACh are widely utilized in cardiac pharmacology; among these one of the most used in antiarrhythmic therapy is the class III agent amiodarone. Detailed studies on the eects of amiodarone in atrial cardiac cells have shown that this drug produces a prolongation of the action potential duration by inhibiting the ACh-activated K + current (Watanabe et al., 1996) . However amiodarone is not a selective blocker of ACh-activated K + channels since it can also block several other ionic conductances (Sato et al., 1994; Singh, 1994) . As part of a screening project aimed at selecting more speci®c channel blockers, we tested in SAN single cells the ability of the amiodarone derivative dronedarone (for detailed structures: Manning et al., 1995) to modify the ACh-activated K + current. SAN myocytes were chosen as the experimental substrate since in these cells I K(ACh) , together with the Figure 4 Current trace recorded in whole-cell conditions using a GTP-gS-containing solution. After establishing the whole-cell con®g-uration with a GTP-gS-containing pipette solution, an upward drift of the baseline current developed indicating the activation of K (ACh) channels. Repetitive perfusions with ACh (10 mM, asterisks) induced currents of decreasing amplitudes. Dronedarone (300 nM) fully reversed the eect of GTP-gS, but did not restore the ability of ACh to activate the current. pacemaker current (I f ), contributes to parasympathetic modulation of heart rate.
The results presented in Figure 1 indicate that dronedarone, like amiodarone, blocks the ACh-activated K + current. Both the ACh-activated and the drug-sensitive currents had a similar reversal potential and were linear in the range 760/ 0 mV. A slight deviation from linearity at negative potential was detected in both I-V curves, possibly re¯ecting a partial voltage-dependent reduction due to the presence of extracellular Cs + (5 mM) (Carmeliet & Mubagwa, 1986 ), which we used in order to block the I f current. The block of I K(ACh) by dronedarone was, on the other hand, linear in the voltage range investigated (775 to 0 mV), as demonstrated by the lack of voltage dependence of fractional inhibition in this range (Figure 2) .
Dronedarone blocks I K(ACh) with an IC 50 of 63.4 nM, a value over one order of magnitude lower than that of amiodarone (*2 mM, Watanabe et al., 1996) . The shallow Hill coecient (0.61) of the dose-block relation might indicate negative cooperative binding of dronedarone to I K(ACh) channels. However, we have no evidence favouring this or alternative mechanisms to explain this characteristic, and further experimentation will be needed to clarify it.
Experimentation in guinea-pig atrial and SAN action potentials showed that dronedarone, like amiodarone, induces signi®cant modi®cation of most action potential parameters and inhibits several currents (I CaL , I CaT , I f , I K ; Rocchetti et al., 1998) . Although a precise determination of IC 50 values is not available for all dronedarone-inhibited currents, where known these values are in the micromolar range. Thus, the very high potency of I K(ACh) block induced by dronedarone points to this drug as a potentially useful speci®c I K(ACh) blocker. For a more complete knowledge of dronedarone eects on cardiac currents, it would also be important to verify the anity for other members of the inward recti®er channel family (Kir), and especially the I Kl current.
Opening of ACh-dependent K + channels is a G-proteinmediated multiple step process triggered by the interaction of ACh with the muscarinic (M2) receptor (Kurachi, 1995) . The identi®cation of the site of I K(ACh) block by dronedarone was therefore an important aspect to evaluate. Watanabe et al. (1996) studied the inhibitory eect of amiodarone on I K(ACh) activated by the muscarinic agonist carbachol, GTP-gS or adenosine; in all cases the IC 50 values for inhibitory action of amiodarone on I K(ACh) were similar (*2 mM). Since the three activation pathways are dierent, the authors concluded that amiodarone must act directly at the channel level and not upstream of the channel protein. The dronedarone molecule is structurally derived from amiodarone, suggesting that the two drugs may have a similar mechanism of action; we con®rmed this hypothesis by verifying that dronedarone blocks AChdependent K + channels previously opened by GTP-gS-induced activation of G proteins. The simplest assumption able to account for the inhibitory action of dronedarone on I K(ACh) is a drug-induced channel block. Current decrease could also be explained by alternative mechanisms such as for example inhibition of G-protein-channel interaction. However, we favour the blocking mechanisms since dronedarone blocks several other channels whose action is not dependent upon Gprotein binding.
Dronedarone is a highly lipophilic molecule that can easily diuse into the cell membrane. Results such as those in Figure  4 , indicating a relatively slow time course of I K(ACh) inhibition (t=29.9 s) are more compatible with a diusion process than with an extracellular blockade mediated by drug entry into the channel. Intracellular diusion was con®rmed by cell-attached experiments where dronedarone was externally perfused, but was missing from the pipette solution; block of single-channel activity under these conditions (Figure 5a ± c) requires that dronedarone diuses through the membrane and into the cytoplasm before reaching its site of block. Although this does not exclude the possibility of an interaction between drug and channel occurring within the membrane, it indicates the need for the free-diusion of drug molecules for block to occur, in agreement with the view that current inhibition could be due to interaction between channels and soluble drug molecules. Channel blockers exert their eects by modifying the open probability (Po) and/or reducing the single channel conductance (Hille, 1992) . The analysis of dronedarone eects on I K(ACh) at the single channel level ( Figure 5) indicates that the drug acts by lowering Po while leaving unaltered the single channel conductance.
In summary our data suggest that dronedarone is an ecient voltage independent blocker of I K(ACh) channels. The low IC 50 (nM range) makes this drug potentially useful as a selective blocker of I K(ACh) since IC 50 values larger by at least one order of magnitude are reported in literature for other ionic currents contributing to electrical activity of SAN cells (Rocchetti et al., 1998) .
